SBMA as a model of polyglutamine diseases: generation of a suitable cell system to study the post-transcriptional modifications of mutant androgen receptor and to discover potential therapeutic drugs

Informations projet

PolyQ mutant AR/SBMA

N° de convention de subvention: 300723

Projet clôturé

Date de début 1 Avril 2013

Date de fin 31 Mars 2015

Financé au titre de

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Coût total € 178 760,70

Contribution de l’UE € 178 760,70

Coordonné par

FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Italy